🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Fulgent Genetics, Inc.

FLGT Healthcare
$19.96 +$0.52 (2.67%)
Market Cap: $566.88 M
Gurus Holding
4
Popularity Rank
#2553
% of Shares Held
0.56%
Net Activity (Q1 2026)
-$6.88 M

Guru Ownership Trend

Guru Analysis for Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics, Inc. (FLGT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.15 M.

Top institutional holders include Paul Tudor Jones and Louis Moore Bacon.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $6.88 M net outflow during the quarter.

Recent activity highlights Louis Moore Bacon who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 78.3%.

Key Holders

Recent Activity Breakdown (Q1 2026)

+$1.2 M
Total Buy Value
New Buys 2
Additions 0
-$8.08 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Fulgent Genetics, Inc. (FLGT)

Major holders include Paul Tudor Jones ($1.02 M), Louis Moore Bacon ($733,372), Cliff Asness ($468,160). According to the latest reported data, 4 tracked investment managers collectively hold approximately 157,655 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $6.88 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited FLGT. The total reported sell value was $8.08 M.

Yes, 2 managers opened new positions in FLGT, and 0 increased their existing holdings. The total reported buy value was $1.2 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -44.8% 64,087 $1.02 M Q1 2026
0.01% New Buy 46,124 $733,372 Q1 2026
0.00% New Buy 29,444 $468,160 Q1 2026
0.00% Reduce -78.3% 18,000 $286,200 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form